In May 2020, the FDA sent warning letters to two different companies: Allergan of California and Ideal Implant Incorporated of Texas. The letter to Allergan states that the company failed to assess the long-term risks associated with two of their implants. The letter to Ideal states that the company failed to meet good manufacturing requirements and also failed to meet adverse event reporting requirements.